Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Lindsay

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|March 6, 2015
Diagnosing FASD in adults: the development and operation of an adult FASD clinic in Ontario, CanadaValerie K Temple, Jillian Ives, Ann Lindsay
Journal of Intellectual & Developmental Disability|January 17, 2025
Long-term outcomes following Fetal Alcohol Spectrum Disorder (FASD) diagnosis in adulthoodValerie K Temple, Sonal Prasad, Svetlana Popova, et al.
International Journal of Clinical Oncology|August 31, 2002
Evidence for the use of chemotherapy in breast cancerJean-Marc Nabholtz, David Reese, Mary-Ann Lindsay, et al.
Journal of Food Science|March 16, 2012
Bioactive dietary polyphenols inhibit heme iron absorption in a dose-dependent manner in human intestinal Caco-2 cellsQianyi Ma, Eun-Young Kim, Elizabeth Ann Lindsay, et al.
Clinical Breast Cancer|November 19, 2002
HER2-positive breast cancer: update on Breast Cancer International Research Group trialsJean-Marc Nabholtz, David M Reese, Mary-Ann Lindsay, et al.
Seminars in Oncology|August 10, 2002
Docetaxel in the treatment of breast cancer: an update on recent studiesJean-Marc A Nabholtz, David M Reese, Mary-Ann Lindsay, et al.
Expert Review of Anticancer Therapy|July 13, 2002
Combination chemotherapy for metastatic breast cancerJean-Marc A Nabholtz, David M Reese, Mary-Ann Lindsay, et al.
Journal of General Internal Medicine|October 7, 2018
Patient Activation Changes as a Potential Signal for Changes in Health Care Costs: Cohort Study of US High-Cost PatientsAnn Lindsay, Judith H Hibbard, Derek B Boothroyd, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2006
A restaurant-associated outbreak of Brainerd diarrhea in CaliforniaDuc J Vugia, Sharon Abbott, Eric D Mintz, et al.
Clinical Breast Cancer|November 12, 2002
Phase III trial comparing granulocyte colony-stimulating factor to leridistim in the prevention of neutropenic complications in breast cancer patients treated with docetaxel/doxorubicin/cyclophosphamide: results of the BCIRG 004 trialJean-Marc Nabholtz, Jacques Cantin, Jose Chang, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|March 6, 2015
Diagnosing FASD in adults: the development and operation of an adult FASD clinic in Ontario, CanadaValerie K Temple, Jillian Ives, Ann Lindsay
Journal of Intellectual & Developmental Disability|January 17, 2025
Long-term outcomes following Fetal Alcohol Spectrum Disorder (FASD) diagnosis in adulthoodValerie K Temple, Sonal Prasad, Svetlana Popova, et al.
International Journal of Clinical Oncology|August 31, 2002
Evidence for the use of chemotherapy in breast cancerJean-Marc Nabholtz, David Reese, Mary-Ann Lindsay, et al.
Journal of Food Science|March 16, 2012
Bioactive dietary polyphenols inhibit heme iron absorption in a dose-dependent manner in human intestinal Caco-2 cellsQianyi Ma, Eun-Young Kim, Elizabeth Ann Lindsay, et al.
Clinical Breast Cancer|November 19, 2002
HER2-positive breast cancer: update on Breast Cancer International Research Group trialsJean-Marc Nabholtz, David M Reese, Mary-Ann Lindsay, et al.
Seminars in Oncology|August 10, 2002
Docetaxel in the treatment of breast cancer: an update on recent studiesJean-Marc A Nabholtz, David M Reese, Mary-Ann Lindsay, et al.
Expert Review of Anticancer Therapy|July 13, 2002
Combination chemotherapy for metastatic breast cancerJean-Marc A Nabholtz, David M Reese, Mary-Ann Lindsay, et al.
Journal of General Internal Medicine|October 7, 2018
Patient Activation Changes as a Potential Signal for Changes in Health Care Costs: Cohort Study of US High-Cost PatientsAnn Lindsay, Judith H Hibbard, Derek B Boothroyd, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2006
A restaurant-associated outbreak of Brainerd diarrhea in CaliforniaDuc J Vugia, Sharon Abbott, Eric D Mintz, et al.
Clinical Breast Cancer|November 12, 2002
Phase III trial comparing granulocyte colony-stimulating factor to leridistim in the prevention of neutropenic complications in breast cancer patients treated with docetaxel/doxorubicin/cyclophosphamide: results of the BCIRG 004 trialJean-Marc Nabholtz, Jacques Cantin, Jose Chang, et al.
Pageof 2